| Old Articles: <Older 7341-7350 Newer> |
|---|
 |
Pharmaceutical Executive
April 1, 2011 |
Restoring Public Trust in Pharma Putting the focus on four steps to cement a new compliance culture.   |
Pharmaceutical Executive
April 1, 2011
Jeff Schindler |
Pharm Exec Wins a Neal Award! Pharm Exec's Editor-in-Chief William Looney was honored March 10 at American Business Media's Neal Awards for "Best Commentary" for his monthly editorial columns. |
Pharmaceutical Executive
April 1, 2011 |
Winning Beyond the Molecule It can take both a clinical and non-clinical approach to win the differentiation competition. |
The Motley Fool
April 16, 2011 |
Pozen Wins Injunction Blocking Generic Migraine Drug The ruling against Par Pharmaceutical comes just in time for Pozen. |
The Motley Fool
April 15, 2011
Brian Orelli |
Dark Clouds Lift Over Pharma Dispute The case of who bought whom in the Merck -Schering-Plough deal has ended in a draw. |
The Motley Fool
April 15, 2011
Brian Orelli |
Fewer Needle Pricks for the Europeans Amylin's once-weekly diabetes drug Bydureon gets a positive recommendation in Europe. |
The Motley Fool
April 15, 2011
Brian Orelli |
Shedding the Pounds Through Divestiture Glaxo plans to sell 19 OTC products. |
The Motley Fool
April 15, 2011
Luke Timmerman |
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug Will this drug be approved in Europe? |
The Motley Fool
April 15, 2011
Frank Vinluan |
GSK to Shed Weight Loss Drug alli and 18 Others GSK wants to focus on fast-growing "priority brands." |
BusinessWeek
April 14, 2011
Rachel Layne |
GE and Siemens: Less May Mean More (Profits) The medical gear makers see an opportunity for their information technology units as hospitals are pressured to improve efficiency and curb waste |
| <Older 7341-7350 Newer> Return to current articles. |
